Improved time to quality of life deterioration in patients with progressive midgut neuroendocrine tumors treated with 177Lu-DOTATATE : The NETTER-1 phase III trial

Strosberg, J. (author)

Univ S Florida, GI Oncol, H Lee Moffitt Canc Ctr, Tampa, FL USA.

Wolin, E. M. (author)

Montefiore Einstein Ctr Canc Care, New York, NY USA.

Chasen, B. (author)

Univ Texas MD Anderson Canc Ctr, Nucl Med, Houston, TX USA.

show more...

Kulke, M. H. (author)

Dana Farber Canc Inst, Gastrointestinal Canc, Boston, MA 02115 USA.

Bushnell, D. (author)

Univ Iowa, Nucl Med, Iowa City, IA 52242 USA.

Caplin, M. (author)

Royal Free Hosp, Neuroendocrine Tumour Unit, London, England.

Baum, R. P. (author)

Zentralklin Bad Berka GmbH, Nucl Med, Bad Berka, Germany.

Kunz, P. (author)

Stanford Univ, Med Ctr, Oncol, Stanford, CA 94305 USA.

Hobday, T. (author)

Mayo Clin, Oncol, Rochester, MN USA.

Hendifar, A. (author)

Cedars Sinai Med Ctr, Oncol, Los Angeles, CA 90048 USA.

Öberg, Kjell, 1946- (author)

Uppsala universitet,Endokrin tumörbiologi

Sierra, M. Lopera (author)

Adv Accelerator Applicat, New York, NY USA.

Ruszniewski, P. (author)

Hop Beaujon, Oncol, Clichy, France.

Krenning, E. (author)

Erasmus MC, Oncol, Rotterdam, Netherlands.

show less...

Univ S Florida, GI Oncol, H Lee Moffitt Canc Ctr, Tampa, FL USA Montefiore Einstein Ctr Canc Care, New York, NY USA. (creator_code:org_t)

2017

2017

English.

In: Annals of Oncology. - 0923-7534 .- 1569-8041. ; 28:S5

Related links:

https://urn.kb.se/re...

• Journal article (other academic/artistic)